G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy

被引：0
|
作者：
Link, H. [1 ]
机构：
[1] Westpfalz Klinikum, Innere Med Klin 1, D-67653 Kaiserslautern, Germany
来源：
ONKOLOGE | 2014年 / 20卷 / 03期
关键词：
D O I：
10.1007/s00761-014-2649-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：268 / 270
页数：3
相关论文
共 50 条
  • [1] Integration of G-CSF in the prophylaxis and treatment of febrile neutropenia
    Siegmund, R
    Illiger, HJ
    MEDIZINISCHE KLINIK, 1996, 91 (02) : 82 - 88
  • [2] G-CSF prophylaxis of febrile neutropenia and infections after chemotherapy [G-CSF-Prophylaxe von febriler Neutropenie und Infektionen nach Chemotherapie]
    Link H.
    Der Onkologe, 2014, 20 (3): : 268 - 270
  • [3] G-CSF for Prophylaxis of Neutropenia and febrile Neutropenia, Anemia in Cancer (2022)
    Link, Hartmut
    UROLOGIE, 2023, 62 (2): : 186 - 186
  • [4] Chemotherapy-induced febrile neutropenia: primary G-CSF prophylaxis indicated during docetaxel cycles
    van Dooijeweert, C.
    van der Wall, E.
    Baas, I. O.
    NETHERLANDS JOURNAL OF MEDICINE, 2019, 77 (09): : 310 - 316
  • [5] G-CSF in the prevention of febrile neutropenia in chemotherapy in breast cancer patients
    Krol, J
    Paepke, S
    Jacobs, VR
    Paepke, D
    Euler, U
    Kiechle, M
    Harbeck, N
    ONKOLOGIE, 2006, 29 (04): : 171 - 178
  • [6] Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with long-acting G-CSF in patients treated with chemotherapy in Germany: results of the epidemiological cross-sectional survey "G-CSF Day"
    Egerer, G.
    Uleer, C.
    Klausmann, M.
    Lueck, A.
    Schroeder, J.
    Schulz, H.
    Fichter, C.
    von der Heyde, E.
    Voss, P.
    Worth, G.
    Burbeck, M.
    Sahlmann, J.
    Potthoff, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 261 - 261
  • [7] G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer Guidelines on supportive treatment part 1
    Link, Hartmut
    UROLOGE, 2022, 61 (05): : 537 - 551
  • [8] G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer: Guidelines on supportive treatment part 1
    Link H.
    best practice onkologie, 2022, 17 (6) : 298 - 314
  • [9] A probability/risk matrix of febrile neutropenia to select patients for G-CSF primary prophylaxis
    Ramchandani Vaswani, A.
    Faez, L.
    Selvi Miralles, M.
    Antonio-Rebollo, M.
    Font Puig, C.
    Espinosa Arranz, J.
    Biosca, M.
    Vicente Rubio, E.
    Jimenez Fonseca, P.
    Carmona-Bayonas, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S275 - S276
  • [10] Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment
    Scotte, Florian
    Simon, Helene
    Laplaige, Philippe
    Antoine, Eric-Charles
    Spasojevic, Caroline
    Texier, Nathalie
    Gouhier, Karine
    Chouaid, Christos
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2021,
12345